Insigneo Advisory Services LLC Acquires 144 Shares of Humana Inc. (NYSE:HUM)

Insigneo Advisory Services LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 14.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,159 shares of the insurance provider’s stock after purchasing an additional 144 shares during the period. Insigneo Advisory Services LLC’s holdings in Humana were worth $367,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC grew its position in shares of Humana by 61.6% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 4,179 shares of the insurance provider’s stock valued at $1,324,000 after acquiring an additional 1,593 shares during the period. Worldquant Millennium Advisors LLC bought a new position in shares of Humana in the 3rd quarter valued at about $50,102,000. Two Sigma Advisers LP grew its position in shares of Humana by 2.4% in the 3rd quarter. Two Sigma Advisers LP now owns 1,043,580 shares of the insurance provider’s stock valued at $330,544,000 after acquiring an additional 24,500 shares during the period. State Street Corp grew its position in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after acquiring an additional 53,272 shares during the period. Finally, Stifel Financial Corp grew its position in shares of Humana by 8.8% in the 3rd quarter. Stifel Financial Corp now owns 59,432 shares of the insurance provider’s stock valued at $18,825,000 after acquiring an additional 4,804 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on HUM. Wells Fargo & Company decreased their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and cut their target price for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. Finally, TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $315.86.

Humana Price Performance

HUM stock opened at $281.73 on Monday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $488.89. The firm has a market cap of $33.92 billion, a P/E ratio of 24.95, a P/E/G ratio of 2.27 and a beta of 0.53. The company’s 50-day moving average price is $272.68 and its two-hundred day moving average price is $326.83.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.26%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.